| Background:Through the evaluation of clinical efficacy anda feasibility of hypertensive patients withclinical application of valsartan combined with amlodipine treatment of coronary heartdisease.Methods:In2013May, will be included in the diagnosis of-2014in May to our hospital fortreatmentofhypertensionandcoronary heart disease in patients with clear, randomized patientswere dividedinto2groups (n=34),thecontrolgroupwasgiven Xiaobendiping Huanshi Pian medication, The observation group received valsartan combined with amlodipine treatment,Study on the treatment outcome of the2groups.Afterdiagnosis, provide the measurement of blood pressure, fluid infusion andsymptomatic treatment and routine treatment on the patients,at the same time according tothe medication,treatment of2groups of patients were as follows.The control group (Xiaobendiping Huanshi Pian scheme): At a dose of10mg,2times a dayorally, Then according to the patient’s blood pressure will be adjusted to a daily doseof40mg,The bloodpressure to normal levels and then changed into20mg/d maintenance, thetreatment lasted for4weeks.Theobservationgroup (valsartan+amlodipine scheme):Valsartan, amlodipine doses for80mgand5mg,1times daily morning oral treatment, and the control group in the same.Results:After treatment, angina pectoris curative effect observation group was94.1%, Tobe significantly higher than that of the control group was73.5%, there was statisticalsignificance (P <0.05). After treatment are improved, and the observation group comparedwith the control group improved more significantly (P <0.05), During the period of the2groups were not there,Theobservationgroup theincidencewas2.9%,17.6%lower to compared with the control group (P <0.05).Conclusion:1.Valsartan, amlodipine, each dose for80mg and5mg, the daily morning Oral1times,compared with nifedipine sustained-release tablets, each dose of10mg,2times a day orally, earlier and improve the symptoms of angina pectoris.2.Valsartan, amlodipine,80mg and5mg at a dose of the antihypertensive effect is better thanthe Xiaobendiping Huanshi Pian, at a dose of10mg.3.Valsartan, amlodipine, each dose was well tolerated in patients with80mgand5mg, theheart rate,Little effect and liver function, biochemical indicators, it is suitablefor clinical application. |